Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document



706.      Andreassen CN, Sørensen FB, Overgaard J & Alsner J: Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material. Radiother. Oncol. 72: 351-356, 2004.

707.      Borgmann K, Dede M, Wrona A, Brammer I, Overgaard J, Dikomey E: For X-irradiated normal human fibroblasts, only half of cell inactivation results from chromosomal damage. Int J Rad Oncol Biol Phys, 58:  445-452, 2004.

708.      Brammer I, Herskind C, Haase O, Rodemann HP, Dikomey E. Induction and repair of radiation-induced DNA double-strand breaks in human fibroblasts are not affected by terminal differentiation. DNA Repair 3:113-20, 2004. 

709.      Grau C, Andreassen CN, Jensen K & Lindegaard JC: Oral complications of radiotherapy in head and neck cancer. Strategies for prevention and management. Am. J. Cancer: 3:291-298. 2004.

710.      Eriksen, JG: Identification of factors important for accelerated repopulation in squamous cell carcinomas of the head and neck. Histopathological characterisation and the expression of EGFr and E-cadherin as indicators for the benefit of reduced overall treatment time of radiotherapy in HNSCC. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 51 pages, 2004.

711.      Eriksen JG, Buffa FM, Alsner J, Steiniche T, Bentzen SM & Overgaard J: Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother. Oncol. 72: 275-282, 2004. 

712.      Eriksen JG, Steiniche T, Askaa J, Alsner J & Overgaard J: The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int. J. Radiat Oncol Biol Phys. 58: 561-566, 2004.  

713.      Eriksen, J.G., Steiniche, T., Søgaard, H. & Overgaard, J.: Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck. APMIS 112: 560-568, 2004. 

714.      Grönroos, T., Bentzen, L., Marjamäki, P., Murata, R., Horsman, M.R., Keiding, S., Eskola, O., Haaparanta, M., Minn, H. & Solin, O.: Comparison of the biodistribution of two hypoxic markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur. J. Nucl. Med. Mol. Imaging 31: 513-520, 2004. 

715.      Herskind C, Fleckenstein K, Lohr J, Li C-Y, Wenz F, Lohr F.: Antitumorale Wirkung von Interferonen und Interleukinen in Kombination mit StrahlentherapieTeil I: Immunologische Grundlagen. Strahlenther Onkol. 180: 187-193, 2004. (DE)

716.      Herskind C, Fleckenstein K, Lohr J, Li C-Y, Wenz F, Lohr F.: Antitumorale Wirkung von Interferonen und Interleukinen in Kombination mit StrahlentherapieTeil II: Strahlenbiologische und immunologische Strategien. Strahlenther Onkol. 180: 331-339, 2004. 

717.      Horsman, M.R. & Overgaard, J.: Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen. Radiother. Oncol. 70: 301-209, 2004. 

718.      Isager, P.: Ocular malignant melanoma. Epidemiological and clinical aspects. Ph.D. Thesis, Faculty of Health Sciences, University of Aarhus, 149 pages, 2004.

719.      Isager, P., Ehlers, N. & Overgaard, J.: Have choroidal and ciliary body melanomas changed during the period 1955-2000? Acta Ophthalmol. Scand.  82: 509-516, 2004. 

720.      Isager, P., Ehlers, N. & Overgaard, J.: Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol. Scand. 82: 517-525, 2004. 

721.      Jensen, A.R., Garne, J.P., Storm, H.H., Engholm, G., Möller, T. & Overgaard, J.: Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden. Acta Oncol. 43: 719-726, 2004. 

722.      Johansen, L.V., Grau, C. & Overgaard, J.: Nodal control and surgical salvage after primary radiotherapy in 1782 patients with laryngeal and pharyngeal carcinoma. Acta Oncol. 43: 486-494, 2004. 

723.      Knap, M., Lundbeck, F. & Overgaard, J.: Early and late treatment-related morbidity following radical cystectomy. Scand. J. Urol. Nephrol. 38: 145-152, 2004. 

724.      Lauridsen, M.C., Garne, J.P., Sørensen, F.B., Melsen, F., Lernevall, A. & Christiansen, P.: Sentinel lymph node biopsy in breast cancer. The experience with the combined method at Aarhus University Hospital. Acta Oncol. 43: 20-26, 2004.

725.      Olsen, K.E., Knudsen, H., Rasmussen, B.B., Balslev, E., Knoop, A., Ejlertsen, B., Nielsen, K.V., Schönau, A. & Overgaard, J.: Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes. Acta Oncol. 43: 35-42, 2004. 

726.      Murata, R. and Horsman, M.R.: Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid. Int. J. Hyperthermia 20: 393-404, 2004. 

727.      Nordsmark, M & Overgaard, J.: Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional control after primary radiotherapy in advanced head and neck cancer. Acta Oncol. 43: 396-403, 2004. 

728.      Safwat A, Aggerholm N, Roitt I, Overgaard J, Hokland M: Tumour burden and Interleukin-2 dose affect the interaction between low-dose total body irradiation and Interleukin 2. Eur. J. Cancer 40: 1412-1417, 2004. 

729.      Safwat, A., Bayoumi, Y., Akkoush, H. & Mahmoud, H.K.: A phase II trial of adjuvant low-dose total body irradiation in non-Hodgkin’s lymphoma patients following standard CHOP. Acta Oncol. 43: 480-485, 2004. 

730.      Schlemmer, B. O., Sørensen, B.S., Overgaard, J., Olsen, K.E., Gjerdrum, L.M., & Nexø, E.: Quantitative PCR - new diagnostic  tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization. Scand. J. Clin. Lab. Invest. 64: 511-522, 2004. 

731.      Siemann, D.W., Chaplin D.J. and Horsman, M.R.: Vascular targeting therapies for treatment of malignant disease. Cancer 100: 2491-2499, 2004. 

732.      Siemann, D.W. and Horsman, M.R.: Targeting the tumour vasculature: a strategy to improve radiation therapy. Expert Rev Anticancer Ther. 4: 321-327, 2004. 

733.      Sørensen, M.: Hypoxi i levende tumorceller og nekrotisk væv i musetumorer målt med PET-scanning, autoradiografi og iltelektrode. “Forskningsårsopgave”, Faculty of Health Sciences, University of Aarhus, 2004.